Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Curia

Explore full profile

Formerly AMRI. Provides contract development and manufacturing services for pharmaceuticals, including drug substance, product, and fill-finish solutions

Albany, United StatesFounded 1991Biotech & Life Sciences
Valuation $1.74B Market cap · Mar/2026
Revenue $1.18B Latest reported FY
EBITDA $209M Latest reported FY

At a glance

Status
Listed
Founded
1991
Headquarters
Albany, United States
Listing
IPO 1999
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom
News
News Portugal clears Apollo's takeover of pharma group Curia Jul 30, 2026

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Siena College
  • Rensselaer Polytechnic Institute

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 startups

Former Curia employees who went on to found companies, sorted by Dealroom signal score.

Kumquat BiosciencesEst. 2018
PINGDA RENUnited States
Signal score73
Oncoheroes BiosciencesEst. 2017
Cesare SpadoniUnited States
Signal score67
Delix TherapeuticsEst. 2019
David OlsonUnited States
Signal score63
Gadea Pharmaceutical GroupEst. 1991
Chester OpalkaSpain
Signal score57
Pharmapotheca AEst. 2014
Harold MecklerUnited States
Signal score49
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
17 countries with
team presence
🇺🇸 United States48.9%
🇮🇳 India19.1%
🇪🇸 Spain11.2%
🇮🇹 Italy11.1%
🇬🇧 United Kingdom3.9%
Top 5 of 17 shown

Patents

Estimated portfolio value
$62M

42 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Curia was the backer or acquirer, 2003–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

9 deals across Curia's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Curia deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Curia's portfolio, mapped.

        Stage
        Period
        9 of 9 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Curia on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Curia on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles